pyrroles has been researched along with Demyelinating Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barati, S; Kashani, IR; Madadi, S; Pasbakhsh, P; Tahmasebi, F | 1 |
| Abboud, H; Al-Hashel, JY; Ismail, II; Massoud, F | 1 |
| Barati, S; Kashani, IR; Madadi, S; Mortezaee, K; Pasbakhsh, P; Tahmasebi, F | 1 |
| Click, B; Regueiro, M | 1 |
| Couturier, BS; Decaux, G; Gankam Kengne, F; Soupart, A | 1 |
| Al-Sabi, A; Daly, D; Dolly, JO; Herron, C; Hoefer, P; Kaza, SK; Kinsella, GK; Metais, C; Nolan, K; Pickering, M | 1 |
| Laczi, F | 1 |
| Cantillo, DS; ComÃn Colet, J; Robledo, GG | 1 |
| MARKLE, V; PAZDER, LH; TAYLOR, JD | 1 |
| Alberta, JA; Guertin, AD; Kim, HA; Mak, KS; Zhang, DP | 1 |
| Ohnishi, M; Rambukkana, A; Tapinos, N | 1 |
| Castellani, RJ; Cohen, ML; Harris, PL; Monnier, VM; Perry, G; Smith, MA | 1 |
3 review(s) available for pyrroles and Demyelinating Diseases
| Article | Year |
|---|---|
Managing Risks with Biologics.
Topics: Antibodies, Monoclonal, Humanized; Biological Products; Demyelinating Diseases; Deprescriptions; Drug Substitution; Gastrointestinal Agents; Humans; Infections; Inflammatory Bowel Diseases; Lymphoma; Melanoma; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Risk; Risk Assessment; Skin Neoplasms; Tumor Necrosis Factor-alpha; Ustekinumab | 2019 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan | 2010 |
9 other study(ies) available for pyrroles and Demyelinating Diseases
| Article | Year |
|---|---|
The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
Topics: Aminopyridines; Animals; Behavior, Animal; Biomarkers; Calcium-Binding Proteins; Chemokine CX3CL1; Corpus Callosum; Cuprizone; CX3C Chemokine Receptor 1; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Injections, Intraventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Myelin Sheath; Pyrroles | 2021 |
CNS demyelination during tofacitinib therapy: First report.
Topics: Animals; Demyelinating Diseases; Humans; Piperidines; Pyrimidines; Pyrroles | 2020 |
Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
Topics: Aminopyridines; Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Indoles; Macrophage Colony-Stimulating Factor; Male; Mice, Inbred C57BL; Microglia; Microscopy, Electron, Transmission; Multiple Sclerosis; Myelin Sheath; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Rotarod Performance Test | 2019 |
Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Astrocytes; Benzamides; Blood-Brain Barrier; Brain Diseases; Chronic Disease; Demyelinating Diseases; Hyponatremia; Male; Microglia; Pyrroles; Rats; Rats, Wistar; Saline Solution, Hypertonic; Urea | 2015 |
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction.
Topics: Animals; Cell Line; Corpus Callosum; Demyelinating Diseases; Drug Design; Humans; Kv1.1 Potassium Channel; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Potassium Channel Blockers; Pyrroles | 2017 |
PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
Topics: Amino Acids; Aminolevulinic Acid; Demyelinating Diseases; Diagnosis, Differential; Fluids and Secretions; Humans; Levulinic Acids; Multiple Sclerosis; Neoplasms; Poliomyelitis; Porphobilinogen; Porphyrias; Porphyrins; Pyrroles; Urine | 1965 |
Microanatomy of axon/glial signaling during Wallerian degeneration.
Topics: Analysis of Variance; Animals; Axotomy; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Coculture Techniques; Demyelinating Diseases; Disease Models, Animal; Embryo, Mammalian; Female; Fluorescent Antibody Technique; Ganglia, Spinal; Gene Expression; Glycoproteins; Immunoprecipitation; Mitogen-Activated Protein Kinase Kinases; Myelin Basic Protein; Myelin Sheath; Neuregulins; Neuroglia; Neurons; Platelet-Derived Growth Factor; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Schwann Cells; Sciatic Neuropathy; Signal Transduction; Sodium Channels; Time Factors; Wallerian Degeneration | 2005 |
ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Butadienes; Cells, Cultured; Chlorocebus aethiops; Coculture Techniques; COS Cells; Demyelinating Diseases; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Leprosy; Mice; Mice, Knockout; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mycobacterium leprae; Nitriles; Pyrimidines; Pyrroles; Rats; Receptor, ErbB-2; Schwann Cells; Sciatic Nerve; Signal Transduction; Trastuzumab | 2006 |
Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.
Topics: Adolescent; Arginine; Astrocytes; Brain Diseases; Child; Cross-Linking Reagents; Crystallins; Demyelinating Diseases; Glycation End Products, Advanced; Humans; Inclusion Bodies; Lysine; Norleucine; Pyrroles | 1997 |